MXPA05014222A - Derivados de difenilpiridina, su preparacion y su aplicacion en terapeutica. - Google Patents
Derivados de difenilpiridina, su preparacion y su aplicacion en terapeutica.Info
- Publication number
- MXPA05014222A MXPA05014222A MXPA05014222A MXPA05014222A MXPA05014222A MX PA05014222 A MXPA05014222 A MX PA05014222A MX PA05014222 A MXPA05014222 A MX PA05014222A MX PA05014222 A MXPA05014222 A MX PA05014222A MX PA05014222 A MXPA05014222 A MX PA05014222A
- Authority
- MX
- Mexico
- Prior art keywords
- substituted
- alkyl
- therapeutic application
- preparation
- diphenylpyridine
- Prior art date
Links
- 230000001225 therapeutic effect Effects 0.000 title abstract 2
- WKAXDAMWMOBXMP-UHFFFAOYSA-N 2,3-diphenylpyridine Chemical class C1=CC=CC=C1C1=CC=CN=C1C1=CC=CC=C1 WKAXDAMWMOBXMP-UHFFFAOYSA-N 0.000 title 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 4
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 125000004429 atom Chemical group 0.000 abstract 2
- 229910052757 nitrogen Inorganic materials 0.000 abstract 2
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 2
- 125000002861 (C1-C4) alkanoyl group Chemical group 0.000 abstract 1
- QIVRGPUIDJPLBR-UHFFFAOYSA-N 5,6-diphenylpyridine-3-carboxamide Chemical class C=1C=CC=CC=1C1=CC(C(=O)N)=CN=C1C1=CC=CC=C1 QIVRGPUIDJPLBR-UHFFFAOYSA-N 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/55—Acids; Esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Addiction (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0307757A FR2856684B1 (fr) | 2003-06-26 | 2003-06-26 | Derives de diphenylpyridine, leur preparation et leur application en therapeutique |
| PCT/FR2004/001581 WO2005000817A2 (fr) | 2003-06-26 | 2004-06-24 | Derives de diphenylpyridine, leur preparation et leur application en therapeutique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA05014222A true MXPA05014222A (es) | 2006-03-13 |
Family
ID=33515448
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA05014222A MXPA05014222A (es) | 2003-06-26 | 2004-06-24 | Derivados de difenilpiridina, su preparacion y su aplicacion en terapeutica. |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US7345059B2 (https=) |
| EP (1) | EP1641758B1 (https=) |
| JP (1) | JP4669839B2 (https=) |
| KR (1) | KR20060025191A (https=) |
| CN (1) | CN1832945A (https=) |
| AR (1) | AR044906A1 (https=) |
| AT (1) | ATE412635T1 (https=) |
| AU (1) | AU2004251914B9 (https=) |
| BR (1) | BRPI0411762A (https=) |
| CA (1) | CA2528619A1 (https=) |
| DE (1) | DE602004017463D1 (https=) |
| FR (1) | FR2856684B1 (https=) |
| IL (1) | IL172733A0 (https=) |
| MX (1) | MXPA05014222A (https=) |
| TW (1) | TW200504019A (https=) |
| WO (1) | WO2005000817A2 (https=) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1492784A4 (en) | 2002-03-28 | 2006-03-29 | Merck & Co Inc | SUBSTITUTED 2,3-DIPHENYLPYRIDINES |
| JP2006510597A (ja) | 2002-09-27 | 2006-03-30 | メルク エンド カムパニー インコーポレーテッド | 置換ピリミジン類 |
| RU2404164C2 (ru) | 2005-04-06 | 2010-11-20 | Ф.Хоффманн-Ля Рош Аг | Производные пиридин-3-карбоксамида в качестве обратных агонистов св1 |
| GB0514739D0 (en) * | 2005-07-19 | 2005-08-24 | Astrazeneca Ab | Therapeutic agents |
| WO2007039797A1 (en) * | 2005-10-03 | 2007-04-12 | Pfizer Products Inc. | Use of cannabinoid receptor-1 antagonist for treating inflammation and arthritis |
| FR2899899A1 (fr) * | 2006-04-14 | 2007-10-19 | Sanofi Aventis Sa | Derives d'aminomethyl pyridine, leur preparation et leur application en therapeutique |
| US7629346B2 (en) | 2006-06-19 | 2009-12-08 | Hoffmann-La Roche Inc. | Pyrazinecarboxamide derivatives as CB1 antagonists |
| FR2904827B1 (fr) | 2006-08-11 | 2008-09-19 | Sanofi Aventis Sa | Derives de 5,6-bisaryl-2-pyridine-carboxamide, leur preparation et leur application en therapeutique comme antiganistes des recepteurs a l'urotensine ii |
| US7781593B2 (en) | 2006-09-14 | 2010-08-24 | Hoffmann-La Roche Inc. | 5-phenyl-nicotinamide derivatives |
| FR2927330B1 (fr) | 2008-02-07 | 2010-02-19 | Sanofi Aventis | Derives de 5,6-bisaryl-2-pyridine-carboxamide, leur preparation et leur application en therapeutique comme antagonistes des recepteurs a l'urotensine ii |
| US8410107B2 (en) | 2010-10-15 | 2013-04-02 | Hoffmann-La Roche Inc. | N-pyridin-3-yl or N-pyrazin-2-yl carboxamides |
| US8669254B2 (en) | 2010-12-15 | 2014-03-11 | Hoffman-La Roche Inc. | Pyridine, pyridazine, pyrimidine or pyrazine carboxamides as HDL-cholesterol raising agents |
| CN102276517B (zh) * | 2011-06-29 | 2012-11-28 | 孙光辉 | 二芳基吡啶类药物的合成方法 |
| WO2014055955A1 (en) * | 2012-10-05 | 2014-04-10 | Rigel Pharmaceuticals, Inc. | Gdf-8 inhibitors |
| JP6710273B2 (ja) * | 2016-05-09 | 2020-06-17 | 日本曹達株式会社 | 環状アミン化合物および有害生物防除剤 |
| EP4302834A3 (en) | 2016-07-12 | 2024-07-17 | Revolution Medicines, Inc. | 2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric shp2 inhibitors |
| JP7240319B2 (ja) | 2017-01-23 | 2023-03-15 | レヴォリューション・メディスンズ，インコーポレイテッド | アロステリックｓｈｐ２阻害剤としての二環式化合物 |
| KR20190110588A (ko) * | 2017-01-23 | 2019-09-30 | 레볼루션 메디슨즈, 인크. | 알로스테릭 shp2 억제제로서의 피리딘 화합물 |
| CA3074690A1 (en) | 2017-09-07 | 2019-03-14 | Revolution Medicines, Inc. | Shp2 inhibitor compositions and methods for treating cancer |
| TW201930292A (zh) | 2017-10-12 | 2019-08-01 | 美商銳新醫藥公司 | 作為變構ｓｈｐ２抑制劑的吡啶、吡嗪和三嗪化合物 |
| JP7361693B2 (ja) | 2017-12-15 | 2023-10-16 | レヴォリューション・メディスンズ，インコーポレイテッド | アロステリックｓｈｐ２阻害剤としての多環式化合物 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2198737B1 (https=) * | 1972-09-13 | 1975-11-28 | Serdex | |
| FR2248027B2 (https=) * | 1973-10-18 | 1977-09-09 | Serdex | |
| FR2612189B1 (fr) * | 1987-03-13 | 1989-06-23 | Roussel Uclaf | Nouveaux derives de la pyridine, leur procede de preparation et les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions les renfermant |
| GB9210436D0 (en) * | 1992-05-15 | 1992-07-01 | Neave Andrew J | A light projector for use in conjunction with light guides |
| FR2741621B1 (fr) * | 1995-11-23 | 1998-02-13 | Sanofi Sa | Nouveaux derives de pyrazole, procede pour leur preparation et compositions pharmaceutiques en contenant |
| FR2816938B1 (fr) * | 2000-11-22 | 2003-01-03 | Sanofi Synthelabo | Derives de 3-aroylindole, leur procede de preparation et les compositions pharmaceutiques en contenant |
| EP1492784A4 (en) * | 2002-03-28 | 2006-03-29 | Merck & Co Inc | SUBSTITUTED 2,3-DIPHENYLPYRIDINES |
| FR2838439B1 (fr) * | 2002-04-11 | 2005-05-20 | Sanofi Synthelabo | Derives de terphenyle, leur preparation, les compositions pharmaceutqiues en contenant |
| FR2838438A1 (fr) * | 2002-04-11 | 2003-10-17 | Sanofi Synthelabo | Derives de diphenylpyridine,leur preparation, les compositions pharmaceutiques en contenant |
-
2003
- 2003-06-26 FR FR0307757A patent/FR2856684B1/fr not_active Expired - Fee Related
-
2004
- 2004-06-24 CA CA002528619A patent/CA2528619A1/fr not_active Abandoned
- 2004-06-24 DE DE602004017463T patent/DE602004017463D1/de not_active Expired - Lifetime
- 2004-06-24 MX MXPA05014222A patent/MXPA05014222A/es active IP Right Grant
- 2004-06-24 JP JP2006516318A patent/JP4669839B2/ja not_active Expired - Fee Related
- 2004-06-24 AT AT04767437T patent/ATE412635T1/de not_active IP Right Cessation
- 2004-06-24 AU AU2004251914A patent/AU2004251914B9/en not_active Ceased
- 2004-06-24 EP EP04767437A patent/EP1641758B1/fr not_active Expired - Lifetime
- 2004-06-24 KR KR1020057024811A patent/KR20060025191A/ko not_active Ceased
- 2004-06-24 CN CNA2004800224859A patent/CN1832945A/zh active Pending
- 2004-06-24 TW TW093118318A patent/TW200504019A/zh unknown
- 2004-06-24 BR BRPI0411762-0A patent/BRPI0411762A/pt not_active IP Right Cessation
- 2004-06-24 WO PCT/FR2004/001581 patent/WO2005000817A2/fr not_active Ceased
- 2004-06-25 AR ARP040102227A patent/AR044906A1/es unknown
-
2005
- 2005-12-21 IL IL172733A patent/IL172733A0/en unknown
- 2005-12-22 US US11/316,510 patent/US7345059B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA2528619A1 (fr) | 2005-01-06 |
| AU2004251914B2 (en) | 2010-01-07 |
| JP4669839B2 (ja) | 2011-04-13 |
| EP1641758A2 (fr) | 2006-04-05 |
| US20060189664A1 (en) | 2006-08-24 |
| EP1641758B1 (fr) | 2008-10-29 |
| WO2005000817A3 (fr) | 2005-03-17 |
| FR2856684B1 (fr) | 2008-04-11 |
| JP2007514638A (ja) | 2007-06-07 |
| IL172733A0 (en) | 2006-04-10 |
| BRPI0411762A (pt) | 2006-08-08 |
| AR044906A1 (es) | 2005-10-05 |
| DE602004017463D1 (de) | 2008-12-11 |
| US7345059B2 (en) | 2008-03-18 |
| WO2005000817A2 (fr) | 2005-01-06 |
| ATE412635T1 (de) | 2008-11-15 |
| AU2004251914A1 (en) | 2005-01-06 |
| AU2004251914B9 (en) | 2010-02-25 |
| CN1832945A (zh) | 2006-09-13 |
| TW200504019A (en) | 2005-02-01 |
| KR20060025191A (ko) | 2006-03-20 |
| FR2856684A1 (fr) | 2004-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA05014222A (es) | Derivados de difenilpiridina, su preparacion y su aplicacion en terapeutica. | |
| BR112012007069A2 (pt) | derivado de fenol | |
| ES2422383T3 (es) | Activadores de urea glucoquinasa | |
| ZA200609261B (en) | Fused quinoline derivative and use thereof | |
| GEP20125523B (en) | Metabolites of (thio) carbamoyl-cyclohexane derivatives | |
| DK1045830T3 (da) | Alfa-aminoamidderivater, der er anvendelige som analgetiske midler | |
| MX2010004893A (es) | Compuesto heterociclico y composicion farmaceutica del mismo. | |
| UA85079C2 (en) | Derivatives of n-(1,5-diphenyl-1h-pyrazol-3-yl) sulphonamide with cb1 receptor affinity | |
| CO5050296A1 (es) | Derivados de 1-arenosulfonil-2-arilo-pirrolidina y de piperidina | |
| EA200401470A1 (ru) | Производные пиперазинилацилпиперидина, их получение и их терапевтическое применение | |
| ATE503746T1 (de) | Neue imidazolidinderivate | |
| BRPI0615248A2 (pt) | derivado tendo atividade agonista de ppar | |
| PL378201A1 (pl) | Sposób farmaceutyczny oraz związki wytwarzane tym sposobem | |
| MXPA05013631A (es) | Derivado heterociclico de metilsulfona. | |
| MX2025003324A (es) | Inhibidores de sik heterociclicos | |
| TW200613297A (en) | Pyrazole derivatives | |
| MXPA02011352A (es) | Nuevos derivados de benzofurano. | |
| TW200420292A (en) | Benzofuran derivative | |
| AR021826A1 (es) | COMPUESTOS DE 2- FENILPIRAN-4-ONA, PROCESOS PARA PREPARARLOS, USO DE UN COMPUESTO INTERMEDIARIO EN DICHOS, COMPOSICIoN FARMACÉUTICA QUE LOS COMPRENDE Y USO DE DICHOS COMPUESTOS Y DICHA COMPOSICIoN PARA LA FABRICACIoN DE UN MEDICAMENTO | |
| GB2470170A (en) | Dithienothiophene derivatives | |
| MX2009005366A (es) | Derivados de pirrol, su preparacion y su utilizacion en terapeutica. | |
| NO941832L (no) | Benzopyranderivater og deres anvendelse | |
| AR029937A1 (es) | Utilizacion de derivados de 2-aminotiazolina para la preparacion de medicamentos, derivados de 2-aminotiazolina y sus procedimientos de preparacion, las composiciones farmaceuticas que contienen dichos derivados, los compuestos intermediarios en la preparacion de dichos derivados y los procedimiento | |
| EA200700179A1 (ru) | Производные пиррола, их получение и их применение в терапии | |
| ECSP045176A (es) | Derivados de 5-(piridin-3-il)-1-azabiciclo[3.2.1]octano, su preparacion y su aplicación en terapeutica |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |